Hataalii Tiisyatonii Begay (HT) participated in a CIRM-funded clinical trial at UCSF for Artemis-SCID, a condition that can be life-threatening or fatal. Photo courtesy Barbara Ries / UCSF. The California Institute for Regenerative Medicine (CIRM) funds innovative cell and gene therapy research and educational programs to advance regenerative medicine in the Golden State. Just as … Continue reading CIRM approves $2.5 million to establish a Patient Support Program
Access and Affordability
Finding solutions for affordable and accessible cell and gene therapies
The California Institute for Regenerative Medicine (CIRM) is not alone in seeking a way to make cell and gene therapies more affordable and accessible. The Innovative Genomics Institute (IGI) just completed a year-long effort to consider how treatments could be made more accessible. This effort involved creating a task force comprised of 30 participants to … Continue reading Finding solutions for affordable and accessible cell and gene therapies